Quelles avancées en immunothérapie spécifique des maladies allergiques ?

Abstract

Allergen immunotherapy remains the only etiologic treatment for allergic diseases. During this last decade significant progresses have occurred in the field of mechanism knowledge of allergen immunotherapy and in the search of new routes of administration or new types of formulation. On the other side, new vaccine development that exploits molecular engineering techniques may allow to create allergen extracts with specific target on the immune system. All of these should promote the use of allergen immunotherapy both by increasing the number of patients and by extending spectrum of indications of immunotherapy beyond allergic respiratory diseases. So, in the future, allergen immunotherapy should remain a corner stone in the management of allergy.